BIOGEN INC. Acquisitions, Net of Cash Acquired
BIOGEN INC. (BIIB) reported Acquisitions, Net of Cash Acquired of $0 for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-10-30.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2025-10-30
- BIOGEN INC. payments to acquire businesses, net of cash acquired for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- BIOGEN INC. payments to acquire businesses, net of cash acquired for the quarter ending 2023-12-31 was $590.50M.
- BIOGEN INC. payments to acquire businesses, net of cash acquired for the quarter ending 2019-12-31 was $0.00.
- BIOGEN INC. payments to acquire businesses, net of cash acquired for the quarter ending 2019-09-30 was $0.00.
- BIOGEN INC. payments to acquire businesses, net of cash acquired for fiscal 2024 was $1.07B, a 84.48% decline from fiscal 2023.
- BIOGEN INC. payments to acquire businesses, net of cash acquired for fiscal 2023 was $6.93B.
- BIOGEN INC. payments to acquire businesses, net of cash acquired for fiscal 2019 was $744.40M.
- BIOGEN INC. payments to acquire businesses, net of cash acquired for fiscal 2018 was $0.00.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 3 month as first filed | Payments to Acquire Businesses, Net of Cash Acquired 6 month | Payments to Acquire Businesses, Net of Cash Acquired 6 month as first filed | Payments to Acquire Businesses, Net of Cash Acquired 9 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month as first filed | Payments to Acquire Businesses, Net of Cash Acquired 12 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | $0.00 10-Q · filed 2025-10-30 | |||||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $1.07B 10-K · filed 2025-02-12 | ||||||
| 2024-09-30 | $1.07B 10-Q · filed 2025-10-30 | |||||||
| 2023-12-31 | $590.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $6.93B 10-K · filed 2025-02-12 | ||||||
| 2023-09-30 | $6.34B 10-Q · filed 2024-10-30 | |||||||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-08 | |||||||
| 2020-06-30 | $0.00 10-Q · filed 2020-07-22 | |||||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-06 | $0.00 derived: sum of 2 quarters · filed 2020-02-06 | $744.40M 10-K · filed 2020-02-06 | |||||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-22 | $744.40M 10-Q · filed 2019-10-22 | ||||||
| 2019-06-30 | $744.40M 10-Q · filed 2020-07-22 | |||||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-06 | $0.00 derived: sum of 2 quarters · filed 2020-02-06 | $0.00 10-K · filed 2020-02-06 | |||||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-22 | $0.00 10-Q · filed 2019-10-22 | ||||||
| 2018-06-30 | $0.00 10-Q · filed 2019-07-24 | |||||||
| 2017-12-31 | $0.00 10-K · filed 2020-02-06 | |||||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-01 | $0.00 derived: sum of 2 quarters · filed 2018-02-01 | $0.00 derived: sum of 3 quarters · filed 2018-02-01 | $0.00 10-K · filed 2018-02-01 | ||||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-26 | $0.00 derived: sum of 2 quarters · filed 2016-10-26 | $0.00 10-Q · filed 2016-10-26 | $0.00 derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-21 | $0.00 10-Q · filed 2016-07-21 | $0.00 derived: sum of 3 quarters · filed 2018-02-01 | $0.00 derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2016-03-31 | $0.00 10-Q · filed 2016-04-21 | $0.00 derived: sum of 2 quarters · filed 2018-02-01 | $0.00 derived: sum of 3 quarters · filed 2018-02-01 | $0.00 derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-01 | $0.00 derived: sum of 2 quarters · filed 2018-02-01 | $0.00 derived: sum of 3 quarters · filed 2018-02-01 | $198.80M 10-K · filed 2018-02-01 | ||||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-26 | $0.00 derived: sum of 2 quarters · filed 2016-10-26 | $198.80M 10-Q · filed 2016-10-26 | $198.80M 10-Q · filed 2015-10-21 | $198.80M derived: sum of 4 quarters · filed 2017-02-02 | |||
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-21 | $198.80M 10-Q · filed 2016-07-21 | $198.80M 10-Q · filed 2015-07-24 | $198.80M derived: sum of 3 quarters · filed 2017-02-02 | $198.80M derived: sum of 4 quarters · filed 2017-02-02 | |||
| 2015-03-31 | $198.80M 10-Q · filed 2016-04-21 | $198.80M 10-Q · filed 2015-04-24 | $198.80M derived: sum of 2 quarters · filed 2017-02-02 | $198.80M derived: sum of 3 quarters · filed 2017-02-02 | $198.80M derived: sum of 4 quarters · filed 2017-02-02 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-02 | $0.00 derived: sum of 2 quarters · filed 2017-02-02 | $0.00 derived: sum of 3 quarters · filed 2017-02-02 | $0.00 10-K · filed 2017-02-02 | ||||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-21 | $0.00 derived: sum of 2 quarters · filed 2015-10-21 | $0.00 10-Q · filed 2015-10-21 | $175.00M 10-Q · filed 2014-10-22 | $0.00 derived: sum of 4 quarters · filed 2016-02-03 | |||
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-24 | $0.00 10-Q · filed 2015-07-24 | $25.00M 10-Q · filed 2014-07-23 | $0.00 derived: sum of 3 quarters · filed 2016-02-03 | $0.00 derived: sum of 4 quarters · filed 2016-02-03 | |||
| 2014-03-31 | $0.00 10-Q · filed 2015-04-24 | $25.00M 10-Q · filed 2014-04-23 | $0.00 derived: sum of 2 quarters · filed 2016-02-03 | $0.00 derived: sum of 3 quarters · filed 2016-02-03 | $0.00 derived: sum of 4 quarters · filed 2016-02-03 | |||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-03 | $0.00 derived: sum of 2 quarters · filed 2016-02-03 | $0.00 derived: sum of 3 quarters · filed 2016-02-03 | $0.00 10-K · filed 2016-02-03 | $15.00M 10-K · filed 2014-02-06 | |||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-22 | $0.00 derived: sum of 2 quarters · filed 2014-10-22 | $0.00 10-Q · filed 2014-10-22 | $0.00 derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-23 | $0.00 10-Q · filed 2014-07-23 | $0.00 derived: sum of 3 quarters · filed 2015-02-04 | $0.00 derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2013-03-31 | $0.00 10-Q · filed 2014-04-23 | $0.00 derived: sum of 2 quarters · filed 2015-02-04 | $0.00 derived: sum of 3 quarters · filed 2015-02-04 | $0.00 derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-04 | $0.00 derived: sum of 2 quarters · filed 2015-02-04 | $0.00 derived: sum of 3 quarters · filed 2015-02-04 | $72.40M 10-K · filed 2015-02-04 | ||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-28 | $0.00 derived: sum of 2 quarters · filed 2013-10-28 | $72.40M 10-Q · filed 2013-10-28 | $77.40M derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-25 | $72.40M 10-Q · filed 2013-07-25 | $77.40M derived: sum of 3 quarters · filed 2014-02-06 | |||||
| 2012-03-31 | $72.40M 10-Q · filed 2013-04-25 | $77.40M derived: sum of 2 quarters · filed 2014-02-06 | ||||||
| 2011-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-06 | $5.00M 10-K · filed 2014-02-06 | ||||||
| 2011-09-30 | $0.00 10-Q · filed 2012-10-25 | |||||||
| 2010-12-31 | $32.50M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-03 | $32.50M derived: sum of 2 quarters · filed 2012-02-03 | $32.50M derived: sum of 3 quarters · filed 2012-02-03 | $72.48M 10-K · filed 2012-02-03 | ||||
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28 | $0.00 derived: sum of 2 quarters · filed 2011-10-28 | $39.98M 10-Q · filed 2011-10-28 | $39.98M derived: sum of 4 quarters · filed 2011-10-28 | ||||
| 2010-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-26 | $39.98M 10-Q · filed 2011-07-26 | $39.98M derived: sum of 3 quarters · filed 2011-07-26 | $39.98M derived: sum of 4 quarters · filed 2011-07-26 | ||||
| 2010-03-31 | $39.98M 10-Q · filed 2011-04-21 | $39.98M derived: sum of 2 quarters · filed 2011-04-21 | $39.98M derived: sum of 3 quarters · filed 2011-04-21 | |||||
| 2009-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2010-02-09 | $0.00 derived: sum of 2 quarters · filed 2010-02-09 | $0.00 10-K · filed 2010-02-09 | |||||
| 2009-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-21 | $0.00 10-Q · filed 2009-10-21 | ||||||
| 2009-06-30 | $0.00 10-Q · filed 2009-07-17 | |||||||
| 2008-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-04 | $50.00M derived: sum of 2 quarters · filed 2011-02-04 | $25.00M 10-K · filed 2011-02-04 | |||||
| 2008-09-30 | $50.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-21 | $25.00M 10-Q · filed 2009-10-21 | ||||||
| 2008-06-30 | -$25.00M 10-Q · filed 2009-07-17 | |||||||
| 2007-12-31 | $95.79M 10-K · filed 2010-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |